We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Guidance Smoothes Advair Generic Approval Process

Law360, Washington (September 11, 2013, 3:13 PM EDT) -- The U.S Food and Drug Administration on Monday issued a draft guidance on how drugmakers should test any planned generic version of GlaxoSmithKline PLC’s blockbuster asthma drug Advair, potentially smoothing the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.